Literature DB >> 7615266

Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study.

S J Rosenstock1, T Jørgensen.   

Abstract

Peptic ulcer prevalence and five year incidence were assessed in a sex and age stratified population sample of 3608 Danish subjects aged 30-60 years. Statements of peptic ulcer disease obtained from questionnaires were scrutinised by reviewing medical records. Life time ulcer prevalence (95% confidence intervals) was 5.6 (4.9-6.4) per cent. Male to female prevalence ratio was 2.2:1, and duodenal to gastric ulcer prevalence ratio was 3.8:1. Thirty two participants with no previous history of peptic ulceration developed an ulcer within the observation period resulting in a five year ulcer incidence of 11.3 (7.4-15.2) per 1000 persons at risk with no demonstrable sex difference. The prevalence of duodenal ulcer has declined in Denmark whereas gastric ulcer prevalence in men has increased slightly. A decline in male duodenal ulcer incidence has probably contributed to the low male to female ulcer incidence ratio, implying that women today incur the same risk of developing an ulcer as men. If such trends continue, they will bring about a new era in ulcer epidemiology characterised by equal incidence in men and women and an even distribution of lesions in the stomach and duodenum.

Entities:  

Mesh:

Year:  1995        PMID: 7615266      PMCID: PMC1382615          DOI: 10.1136/gut.36.6.819

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

1.  Estimability and estimation in case-referent studies.

Authors:  O Miettinen
Journal:  Am J Epidemiol       Date:  1976-02       Impact factor: 4.897

2.  Prevalence of peptic ulcer in India: an endoscopic and epidemiological study in urban Kashmir.

Authors:  M S Khuroo; R Mahajan; S A Zargar; G Javid; S Munshi
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

3.  The incidence of duodenal ulcer in Copenhagen county.

Authors:  O Bonnevie
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

4.  20 years of hospital admissions for peptic ulcer in England and Wales.

Authors:  D Coggon; P Lambert; M J Langman
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

5.  A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists.

Authors:  J H Kurata; A N Nogawa; D E Abbey; F Petersen
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

6.  Prevalence of symptoms of dyspepsia in the community.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1989-01-07

7.  Survival in peptic ulcer.

Authors:  O Bonnevie
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

8.  Studies of gastric ulcer disease by community-based gastroenterologists.

Authors:  S R Brazer; M P Tyor; F S Pancotto; N J Nickl; N M Wildermann; F E Harrell; D B Pryor
Journal:  Am J Gastroenterol       Date:  1990-07       Impact factor: 10.864

9.  Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids.

Authors:  D A Henry; A Johnston; A Dobson; J Duggan
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

10.  Incidence of gallstones in a Danish population.

Authors:  K H Jensen; T Jørgensen
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  21 in total

1.  Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes.

Authors:  S Rosenstock; L Kay; C Rosenstock; L P Andersen; O Bonnevie; T Jørgensen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 2.  Gender differences, aging and hormonal status in mucosal injury and repair.

Authors:  Irina Grishina; Anne Fenton; Sumathi Sankaran-Walters
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

3.  In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana.

Authors:  Christiana Bola A Adeniyi; Temitope Olufunmilayo Lawal; Gail B Mahady
Journal:  Pharm Biol       Date:  2009-01-01       Impact factor: 3.503

4.  Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study.

Authors:  S Rosenstock; T Jørgensen; L Andersen; O Bonnevie
Journal:  J Epidemiol Community Health       Date:  2000-06       Impact factor: 3.710

5.  Estrogen regulation of duodenal bicarbonate secretion and sex-specific protection of human duodenum.

Authors:  Biguang Tuo; Guorong Wen; Jinqi Wei; Xuemei Liu; Xue Wang; Yalin Zhang; Huichao Wu; Xiao Dong; Jimmy Y C Chow; Volker Vallon; Hui Dong
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

6.  Socioeconomic factors in Helicobacter pylori infection among Danish adults.

Authors:  S J Rosenstock; L P Andersen; C V Rosenstock; O Bonnevie; T Jørgensen
Journal:  Am J Public Health       Date:  1996-11       Impact factor: 9.308

7.  Prevalence of gastrointestinal diseases in two British national birth cohorts.

Authors:  A G C Ehlin; S M Montgomery; A Ekbom; R E Pounder; A J Wakefield
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

8.  Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and Helicobacter pylori infection.

Authors:  Hui-Chao Wu; Bi-Guang Tuo; Wei-Min Wu; Yuan Gao; Qing-Qing Xu; Kui Zhao
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

9.  Gender-specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion.

Authors:  Anders Smith; Cheyanne Contreras; Kwang Hyun Ko; Jimmy Chow; Xiao Dong; Biguang Tuo; Hong-hai Zhang; Dong-bao Chen; Hui Dong
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

10.  Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults.

Authors:  S Rosenstock; T Jørgensen; O Bonnevie; L Andersen
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.